• Skip to primary navigation
  • Skip to main content
  • Skip to footer

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Who is SAGES?
    • SAGES Mission Statement
    • Advocacy
    • Strategic Plan, 2020-2023
    • Committees
      • Request to Join a SAGES Committee
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Full Committee Rosters
      • SAGES Past Presidents
    • Donate to the SAGES Foundation
    • SAGES Store
    • Awards
      • George Berci Award
      • Pioneer in Surgical Endoscopy
      • Excellence In Clinical Care
      • International Ambassador
      • IRCAD Visiting Fellowship
      • Social Justice and Health Equity
      • Excellence in Community Surgery
      • Distinguished Service
      • Early Career Researcher
      • Researcher in Training
      • Jeff Ponsky Master Educator
      • Excellence in Medical Leadership
      • Barbara Berci Memorial Award
      • Brandeis Scholarship
      • Advocacy Summit
      • RAFT Annual Meeting Abstract Contest and Awards
    • “Unofficial” Logo Products
  • Meetings
    • NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2024 Scientific Session Call For Abstracts
      • 2024 Emerging Technology Call For Abstracts
    • CME Claim Form
    • Industry
      • Advertising Opportunities
      • Exhibit Opportunities
      • Sponsorship Opportunities
    • Future Meetings
    • Related Meetings Calendar
  • Join SAGES!
    • Membership Benefits
    • Membership Applications
      • Active Membership
      • Affiliate Membership
      • Associate Active Membership
      • Candidate Membership
      • International Membership
      • Medical Student Membership
    • Member News
      • Member Spotlight
      • Give the Gift of SAGES Membership
  • Patients
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Patient Information Brochures
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find a SAGES Member
  • Publications
    • SAGES Stories Podcast
    • SAGES Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Patient Information Brochures
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • SCOPE – The SAGES Newsletter
    • COVID-19 Annoucements
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • OpiVoid.org
    • SAGES.TV Video Library
    • Safe Cholecystectomy Program
      • Safe Cholecystectomy Didactic Modules
    • Masters Program
      • SAGES Facebook Program Collaboratives
      • Acute Care Surgery
      • Bariatric
      • Biliary
      • Colorectal
      • Flexible Endoscopy (upper or lower)
      • Foregut
      • Hernia
      • Robotics
    • Educational Opportunities
    • HPB/Solid Organ Program
    • Courses for Residents
      • Advanced Courses
      • Basic Courses
    • Fellows Career Development Course
    • Robotics Fellows Course
    • MIS Fellows Course
    • Facebook Livestreams
    • Free Webinars For Residents
    • SMART Enhanced Recovery Program
    • SAGES OR SAFETY Video
    • SAGES Top 21 MIS Procedures
    • SAGES Pearls
    • SAGES Flexible Endoscopy 101
    • SAGES Tips & Tricks of the Top 21
  • Opportunities
    • NEW-Area of Concentrated Training Seal (ACT)-Advanced Flexible Endoscopy
    • SAGES Fellowship Certification for Advanced GI MIS and Comprehensive Flexible Endoscopy
    • Multi-Society Foregut Fellowship Certification
    • SAGES Research Opportunities
    • Fundamentals of Laparoscopic Surgery
    • Fundamentals of Endoscopic Surgery
    • Fundamental Use of Surgical Energy
    • Job Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
  • OWLS
  • Log In

Clinicopathological Study of Esophagectomized Specimens in Patients with Endoscopic Complete Response Following Chemoradiation in Locally Advanced Esophageal Cancer

Chadin Tharavej, Patpong Navicharern, Supaut Pungpapong, Krit Kittisin, Suthep Udomsaweangsup. Chulalongkorn University

Background: Upfront chemoradiation (CRT) currently is a standard treatment for locally advanced esophageal cancer. Whether surgery is needed in patients with endoscopic complete response is debatable. We hypothesized that significant number of clinical endoscopic complete response have microscopic residual disease. The aim of this study was to invesitigate clinicopathological outcome of esophagectomy in patients with endoscopic complete response after CRT in locally advanced squamous cell esophageal cancer.

Methods: Patients with locally advanced resectable squamous cell esophageal cancer (T3-T4/N0-1/M0) were included. Patients with significant comorbidity or unfit for surgery were excluded. All patients had planned tranthoracic esophagectomy with 2-field lymphadenectomy 4 months after concurrent 50 Gy of radiotherapy with 2 cycles of 5FU and cis-platin. Endoscopic complete response (enCR) was defined when no mucosal abnormality/negative biopsies were identified. Clinicopathological outcome was examined.

Results: Of 67 patients treated with upfront chemoradiation, 51 had endoscopic complete response and underwent esophagectomy with 2-field lymphadenectomy. Operative mortality was 2%. R-0 resection was 89%. Incidence of pathological complete response (pCR) was 43% and 57% had histologic residual tumor. Five-year survival was 30.5% (50% for pCR and 20% for non-pCR, p=0.04 ). Locoregional recurrence was identified in 24% of enCR with esophageal resection. On histologic examination of 29 esophagectomized specimen with residual viable cancer cell, only 10 (34%) out of 29 specimens had tumor cell presented in mucosal layer.

Conclusion: More than 50% of advanced squamous cell esophageal cancer with clinical endoscopic response after CRT had microscopic residual disease which was R-0 amenable. Viable cancer cell presented in mucosal layer only about a third. Surveillance strategy with intensive endoscopic biopsy would not be able to detect micro residual disease in significant number of esophageal cancer patients with endoscopic complete response following chemoradiation. Planned esophagectomy in endoscopic complete response after CRT was safe and acceptable long term survival. Until an accurate marker for residual disease detection is established, planned esophagectomy, should be an optional treatment in fit patients after CRT for locally advanced squamous cell esophageal cancer.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 77670

Program Number: S026

Presentation Session: Foregut 1

Presentation Type: Podium

12

Share this:

  • Twitter
  • Facebook
  • LinkedIn
  • Pinterest
  • WhatsApp
  • Reddit

Related

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064
1-310-437-0544
[email protected]
Monday - Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Facebook
  • Twitter
  • YouTube
  • Instagram
  • TikTok

Important Links

SAGES 2024 Meeting Information

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

 

  • taTME Study Info
  • Foundation
  • SAGES.TV
  • MyCME
  • Educational Activities

Copyright © 2023 Society of American Gastrointestinal and Endoscopic Surgeons